BSEAGM/EGM28 Sept 2026 · 28 Sept 2026, 05:36 pm
PFA
Shree Ganesh Biotech (India) Ltd · 539470
✦ AI SummaryResults
Shree Ganesh Biotech (India) Ltd has informed about the outcome of its 16th Annual General Meeting (AGM) held on September 28, 2026, where two ordinary resolutions were passed, including the adoption of audited financial statements for FY 2025-26 and the re-appointment of Mr. Aman Patel as a director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shree Ganesh Biotech (India) Ltd - 539470 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attachments (1)
📄pdf
Download →
4b59aa3e-2f27-418a-8265-0b94c51df62b.pdf
View document text
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED
CIN: L70101WB1982PLC121196
Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016
Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar
Date: 28.09.2026
To, To, To,
Listing Department, The Secretary, Head - Listing
BSE Limited, The Calcutta Stock Metropolitan Stock Exchange of
P J Tower, Dalal Exchange Ltd, India Limited
Street 7, Lyons Range, Vibgyor Towers, 4th floor, Plot
Mumbai-400001 Kolkata - 700001 No C 62, Opp. Trident Hotel
Bandra Kurla Complex, Bandra
(E),
Mumbai – 400098
Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES
Dear Sir/Madam,
Subject: Proceedings of 16th Annual General Meeting of the Company held on 28th September 2026
In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we hereby inform you that
the following businesses were transacted at the Annual General Meeting of the Company held
on Monday the 28th September 2026 at 03:00 P.M. at registered office of the company.
1. Ordinary Resolution for adoption of the audited financial statements of the Company for the
Financial Year ended 31st March 2026 and Reports of the Directors and Auditors thereon.
2. Ordinary Resolution for re-appointment of Mr. Aman Patel (DIN: 08483544), as director of
the Company who retires by rotation.
The above businesses were transacted and passed by the shareholders at Annual General
Meeting.
The AGM commenced at 03:00 P.M and concluded at 03:30 P.M.
Details of voting results as required under Regulation 44(3) of Listing Regulations are being
submitted separately.
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED
CIN: L70101WB1982PLC121196
Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016
Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar
Kindly take note of the above.
Thanking you,
Yours faithfully,
For, SHREE GANESH BIO-TECH (INDIA) LIMITED
Aman Patel
Whole-Time Director